Nitric oxide and myocardial function in heart failure: Friend or foe?

Heart

Volumn 88, Issue 6, 2002, Pages 564-566

  Cotton, J M ^a   Kearney, M T ^a   Shah, Ajay M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

CORRELATION ANALYSIS; DISEASE COURSE; ENZYME ACTIVITY; ENZYME LOCALIZATION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART RATE; HUMAN; INOTROPISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY;

EID: 0036897624     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.88.6.564     Document Type: Short Survey

References (36)

1. Furchgott R, Zawadzki J. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
2. Shah AM, MacCarthy PA. Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther 2000;86:49-86.
3. Balligand JL, Ungureanu-Longrois D, Simmons WW, et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 1994;269:27580-8.
4. Kojda G, Kottenberg K, Nix P, et al. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular muscle. Circ Res 1996;78:91-101.
5. Vila-Petroff MG, Younes A, Egan J, et al. Activation of distinct cAMP-dependant and cGMP-dependant pathways by nitric oxide in cardiac myocytes. Circ Res 1999;30:1215-23.
6. Mohan P, Brutsaert D, Paulus W, et al. Myocardial response to nitric oxide and cGMP. Circulation 1996;93:1223-9.
7. Cotton JM, Kearney MT, MacCarthy PA, et al. Effects of nitric oxide synthase inhibition on basal function and the force-frequency relationship in the normal and failing human heart in vivo. Circulation 2001;104:2318-23.
8. Campbell DL, Stamler JS, Strauss HC. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 1996;108:277-93.
9. Xu L, Eu JP, Meissner G, et al. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 1998;279:234-7.
10. Grocott-Mason R, Anning P, Evans H, et al. Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol 1994;267:H1804-13.
11. Shah AM, Spurgeon HA, Sollott SJ, et al. 8-Bromo cyclic GMP reduces the myofilament response to calcium in intact cardiac myocytes. Circ Res 1994;74:970-8.
12. Layland J, Li J-M, Shah AM. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in isolated cardiac myocytes. J Physiol 2002;540.2:457-67.
13. Heusch G, Post H, Michel MC, et al. Endogenous nitric oxide and myocardial adaptation to ischemia. Circ Res 2000;87:146-52.
14. Paulus W, Vantrimont P, Shah A. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Circulation 1994;89:2070-8.
15. Paulus WJ, Vantrimpont PJ, Shah AM. Paracrine coronary endothelial control of left ventricular function in humans. Circulation 1995;92:2119-26.
16. Musialek P, Lei M, Brown HF, et al. Nitric oxide can increase heart rate by stimulating the hyperpolarization-activated inward current, l(f). Circ Res 1997;81:60-8.
17. Xie Y-W, Shen W, Zhao G, et al. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Circ Res 1996;79:381-7.
18. 2 administration in canine hearts. Cardiovasc Res 1999;42:232-9.
19. Crystal GJ, Zhou X, Halim AA, et al. Nitric oxide does not modulate whole body oxygen consumption in anesthetized dogs. J Appl Physiol 1999;86:1944-9.
20. Pinsky D, Patton S, Mesaros S, et al. Mechanical transduction of nitric oxide synthesis in the beating heart. Circ Res 1997;81:372-9.
21. Prendergast B, Sagach V, Shah A. Basal release of nitric oxide augments the Prank-Starling response in the isolated heart. Circulation 1997;96:1320-9.
22. 2+ release cardiomyocytes. Nat Cell Biol 2001;3:867-73.
23. Vandecasteele G, Eschenhagen T, Scholz H, et al. Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nat Med 1999;5:331-4.
24. Hare J, Givertz M, Creager M, et al. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: Potentiation of beta-adrenergic inotropic responsiveness. Circulation 1998;97:161-6.
25. Post H, Schulz R, Gres P, et al. No involvement of nitric oxide in the limitation of beta-adrenergic inotropic responsiveness during ischemia. Am J Physiol 2001;281:H2392-7.
26. deBelder A, Radomski M, Why H, et al. Nitric oxide synthase activities in human myocardium. Lancet 1993;341:84-5.
27. Haywood GA, Tsao PS, von der Leyen HE, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996;93:1087-94.
28. Drexler H, Kastner S, Strobel A, et al. Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J Am Coll Cardiol 1998;32:955-63.
29. Fukuchi M, Hussain SN, Giaid A. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: Their relation to lesion site and beta-adrenergic receptor therapy. Circulation 1998;98:132-9.
30. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997;100:2153-7.
31. Harding SE, Davies CH, Money-Kyrle AM, et al. An inhibitor of nitric oxide synthase does not increase contraction or beta-adrenoceptor sensitivity of ventriculor myocytes from failing human heart. Cardiovasc Res 1998;40:523-9.
32. Paulus WJ, Kastner S, Vanderheyden M, et al. Myocardial contractile effects of L-arginine in the human allograft. J Am Coll Cardiol 1997;29:1332-8.
33. Stein B, Eschenhagen T, Rudiger J, et al. Increased expression of constitutive nitric oxide synthase II, but not inducible nitric oxide synthase II, in human heart failure. J Am Coll Cardiol 1998;32:1179-86.
34. Bortunek J, Shah A, Vanderheyden M, et al. Dobutamine enhances cordiodepressant effects of receptor mediated coronary endothelial stimulation. Circulation 1997;95:90-6.
35. Hare JM, Lofthouse RA, Juang GJ, et al. Contribution of caveolin protein abundance to augmented nitric oxide signaling in conscious dogs with pacing-induced heart failure. Circ Res 2000;86:1085-92.
36. Heymes C, Vanderheyden M, Bronzwaer J, et al. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation 1999;99:3009-16.